BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12934492)

  • 1. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
    Mendeleeva LP
    Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of bone marrow transplantation in the treatment of leukemia].
    Robak T
    Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia.
    Fauser AA; Köchling G; Digel W; Finke J; Thiel M; Heinz J; Bross KJ; Dölken G; Mertelsmann R
    Bone Marrow Transplant; 1993; 11 Suppl 1():83. PubMed ID: 8448558
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation. The state of the art.
    Thomas ED
    Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
    [No Abstract]   [Full Text] [Related]  

  • 5. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
    Schneider EM; Dörries K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1271-3. PubMed ID: 8382856
    [No Abstract]   [Full Text] [Related]  

  • 6. [New therapeutic possibilities for leukemia in adults. Indications and progress measures for allogeneic bone marrow transplantation].
    Brinch L; Evensen SA; Albrechtsen D; Egeland T
    Tidsskr Nor Laegeforen; 1991 Jan; 111(3):316-9. PubMed ID: 2000611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
    Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
    De Witte T; Vreugdenhil G; Schattenberg A
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):57-60. PubMed ID: 8351721
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Ringdén O; Horowitz MM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2989-92. PubMed ID: 2650409
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation for leukemia after conditioning with busulfan and cyclophosphamide. Bone marrow morphology in the early recovery phase.
    Cao DC; Tutschka PJ
    Chin Med J (Engl); 1991 Apr; 104(4):267-76. PubMed ID: 2065543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
    Buckner CD; Clift RA; Appelbaum FR; Storb R; Petersen FB; Sanders JE; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1991; 7 Suppl 2():6-8. PubMed ID: 1878723
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency and indication of unrelated bone marrow transplants in Europe. European Group of Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1993; 11 Suppl 1():62-5. PubMed ID: 8448551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery.
    Van der Lely N; De Witte T; Raemaekers J; Schattenberg A; Haanen C
    Bone Marrow Transplant; 1989 Mar; 4(2):163-6. PubMed ID: 2650786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies on the role of bone marrow transplantation for patients with hematopoietic malignancies.
    Geller RB
    Mt Sinai J Med; 1994 Jan; 61(1):13-22. PubMed ID: 8183287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual physician practice variation in hematopoietic cell transplantation.
    Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
    J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplants in ALL.
    Barrett AJ; Horowitz MM
    Bone Marrow Transplant; 1992; 10 Suppl 1():30-6. PubMed ID: 1521088
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
    Bernasconi C; Lazzarino M; Canevari A; Morra E; Castelli G; Brusamolino E; Alessandrino EP; Pagnucco G; Orlandi E; Castagnola C
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439
    [No Abstract]   [Full Text] [Related]  

  • 20. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
    Santos GW
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.